PRODUCTS & SERVICES


Our capabilities place AAHI at the intersection of emerging sciences, medicine, and the business of biotech, enabling us to provide technologies, services, and insights that advance the state-of-the art for the entire biomedical community.

AAHI provides custom vaccine and immunotherapy solutions with next generation features and functionality, translating into unique products capable of addressing pressing global health needs.

AAHI is uniquely positioned to support development of products based on our immune-enhancing platforms from bench to clinic. Our partnerships with large pharmaceuticals enable collaborations to bring our products to market, providing accessibility around the world.

AAHI PIPELINE

By Platform Technology

AAHI’S ADJUVANT TECHNOLOGY HAS BEEN CLINICALLY TESTED IN NEARLY 10,000 HUMAN VOLUNTEERS AND HAS AN OUTSTANDING SAFETY PROFILE.

ADJUVANT

Preclinical

GMP/Tox

Phase 1

Phase 2

Phase 3

Squalene Emulsion

SE




TLR 4 Agonists





GLA-AF/Alum








TLR/ 7/8 Agonists








TLR 4 Agonists + Saponin








Dual Agonist





RNA DELIVERY VEHICLE

Preclinical

GMP/Tox

Phase 1

Phase 2

Phase 3

Nanostructured Lipid Carrier

NLC




By Disease Indication

AAHI’s immune-enhancing platform technologies support vaccine development around the world.

INDICATION

Preclinical

GMP/Tox

Phase 1

Phase 2

Phase 3

COVID-19

Adjuvanted Protein Vaccine (4)








RNA Vaccine






Tuberculosis

Adjuvanted Protein Vaccine (2)








RNA Vaccine




HIV

Adjuvanted Protein Vaccine (9)








RNA Vaccine




Flavivirus

RNA Vaccine

Bivalent (Zika, yellow fever)





Pandemic Influenza

RNA Vaccine

Spray-dried




RNA Vaccine

Bivalent (H7N9, H5N1)



Malaria

Adjuvanted Protein Vaccine (5)







Hepatitis C

Adjuvanted Protein Vaccine







Neglected Tropical Diseases

Hookworm





Schistosomiasis (2)




All Adjuvanted Protein Vaccines

Schistosomiasis





Leprosy




SERVICES

AAHI offers world-class expertise in the design, formulation, and manufacture of vaccines, adjuvants, immunotherapies, and their components.